Table 4.
Hemodynamic impact of lung re-expansion therapy in patients undergoing cardiac surgery.
| Variable | PEEP 10 | PEEP 12 | PEEP 15 | Pa |
|---|---|---|---|---|
| HR (bpm) | ||||
| Before | 97.6±12.6 | 92.3±13.9 | 86.6±15.1 | 0.21 |
| After | 92±13.2 | 90±14.6 | 87.1±13.3 | 0.7 |
| Pb | 0.15 | 0.72 | 0.93 | |
| SBP (mmHg) | ||||
| Before | 119.7±10.6 | 121.4±11.6 | 114.8±9.2 | 0.31 |
| After | 118±12.8 | 123.3±14.9 | 118.5±17.5 | 0.60 |
| P | 0.72 | 0.67 | 0.58 | |
| DBP (mmHg) | ||||
| Before | 62.8±9 | 60.7±8.4 | 62.9±11.7 | 0.84 |
| After | 61.4±10.3 | 60.2±7.8 | 67±18.9 | 0.74 |
| P | 0.35 | 0.84 | 0.24 | |
| MAP (mmHg) | ||||
| Before | 80.2±7.7 | 79.9±8.6 | 77.7±8.5 | 0.92 |
| After | 79±8.8 | 79.4±7.1 | 84.2±16.9 | 0.76 |
| P | 0.31 | 0.99 | 0.16 |
a
Kruskal-Wallis test;
b
Wilcoxon test; PEEP=positive end expiratory pressure; HR=heart rate; SBP=systolic blood pressure; DBP=diastolic blood pressure; MAP=mean arterial pressure